Balancing pharma, biomarkers, and therapeutics

The seventh episode of Neurotech Daily, features Jonathan Berent (JB), founder and CEO of NextSense.

NextSense is developing clinical grade in-ear EEG for epilepsy and sleep disorder detection. Originally a spin-out from Google X, JB's path to NextSense is an intriguing one. Read more here: from WIRED

For more about NextSense, visit: https://www.nextsense.io/
Visit our website, https://www.neurotechdaily.com or reach out to us @neurotechdaily on Twitter. For more neurotech content, check out https://www.neurotechjp.com